# Weight Loss Drug by Eli Lilly Shows Promising Results in Reducing Diabetes Risk ## Key Points: – Recently, Eli Lilly’s weight loss drug has shown impressive results in reducing the risk of diabetes by 88% after stopping treatment. – The drug initially achieved a 94% reduction in the risk of diabetes during the treatment phase, with an 88% risk reduction sustained even after stopping the medication. – This study sheds light on the potential of weight loss drugs in not only aiding in weight reduction but also in preventing the onset of diabetes. – The findings suggest a promising approach to managing weight and diabetes risk simultaneously through pharmaceutical interventions. ## Hot Take: Eli Lilly’s weight loss drug demonstrating an 88% reduction in diabetes risk even after stopping treatment signifies a significant breakthrough in the realm of weight management and diabetes prevention. This study highlights the importance of exploring innovative pharmaceutical solutions to tackle weight-related issues and associated health risks effectively. **Weight Loss Disclaimer:** *Individual results may vary. Please consult with a healthcare professional before starting any weight loss program.* To learn more about effective weight management strategies and personalized healthcare, contact Mindful Evolution on our website https://yourmindfulevolution.com or call/text us at 954-639-9960. We offer telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.